Interdependence of oestrogen and insulin-like growth factor-I in the brain: Potential for analysing neuroprotective mechanisms by Méndez, Pablo et al.
REVIEW
Interdependence of oestrogen and insulin-like growth factor-I in the
brain: potential for analysing neuroprotective mechanisms
Pablo Mendez, Iñigo Azcoitia1 and Luis Miguel Garcia-Segura
Instituto Cajal, CSIC, E-28002 Madrid, Spain
1Departamento de Biología Celular, Facultad de Biología, Universidad Complutense, E-28040 Madrid, Spain
(Requests for offprints should be addressed to L M Garcia-Segura, Instituto Cajal, CSIC, Avenida Doctor Arce 37, E-28002 Madrid, Spain;
Email: lmgs@cajal.csic.es)
Abstract
The actions of oestradiol in the brain involve interaction
with growth factors, such as insulin-like growth factor-I
(IGF-I). Many cells in the brain co-express receptors for
oestradiol and IGF-I and both factors interact to regulate
neural function. The relationship of oestrogen receptor 
with IGF-I receptor through the mitogen-activated pro-
tein kinase and the phosphoinositide 3-kinase signalling
pathways may represent the point of convergence used by
these two factors to cooperatively modulate neuritic
growth, synaptic plasticity, neuroendocrine events, repro-
ductive behaviour and neuronal survival. In addition, Akt
and glycogen synthase kinase 3 are key molecular targets
to explain the interaction of oestrogen and IGF-I receptor
signalling in the promotion of neuroprotection.
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Introduction
The nervous system is a target for the ovarian hormone
oestradiol. This hormone regulates brain development and
function, acting on neurons, synapses and glial cells
(Chowen et al. 2000, McEwen 2002). For many years it
was considered that the actions of oestradiol in the brain
were restricted to areas involved in neuroendocrine regu-
lation and the control of sex behaviour. Today it has
become evident that oestradiol exerts a broad spectrum of
actions, including neuroprotective eﬀects, in many brain
areas that are not directly related to reproduction (Chowen
et al. 2000, Garcia-Segura et al. 2001, Stein 2001, Wise
et al. 2001, McEwen 2002). One of the main mechanisms
of action of oestradiol in the brain, as in other organs, is the
activation of nuclear oestrogen receptors. These receptors
belong to the steroid/thyroid nuclear receptor superf-
amily, and once activated homo- or heterodimerize,
interact with DNA and recruit a cohort of transcriptional
cofactors to the regulatory regions of target genes. The two
mammalian oestrogen receptors cloned to date,  and ,
are widely distributed through the central nervous system.
In addition oestradiol exerts rapid membrane eﬀects on
neural cells, modulating ion channels, neurotransmitter
transporters, levels of intracellular calcium and other
second messengers and phosphorylation of diﬀerent
kinases (Chowen et al. 2000, Cardona-Gomez et al. 2001,
Stein 2001, Wise et al. 2001, McEwen 2002).
In this review we focus on one of the mechanisms of
action of oestradiol in the brain: the interaction with
the signalling of insulin-like growth factor-I (IGF-I).
First, we present several lines of evidence of crosstalk
between oestradiol and IGF-I in the brain. Then we
analyse the implications of this crosstalk for neuro-
protection. Finally we discuss the molecular mech-
anisms involved in the interaction of oestrogen receptors
and IGF-I receptors in the brain and their potential
implications for neuroprotection.
Crosstalk between oestradiol and IGF-I in the brain
In several cellular systems there is a crosstalk between the
signalling of oestradiol and IGF-I (Ghahary et al. 1990,
Klotz et al. 2002, Sato et al. 2002). Among the most
studied examples are breast cancer cells: both factors play
a role in the development and proliferation of breast cancer
cells and show synergistic interactions in the activation of
cell-cycle components, resulting in increased proliferation
rates (Dupont & Le Roith 2001, Hamelers et al. 2002,
Martin & Stoica 2002, Hamelers & Steenbergh 2003,
Song et al. 2004, Thordarson et al. 2004). Interactions
11
Journal of Endocrinology (2005) 185, 11–17
0022–0795/05/0185–011  2005 Society for Endocrinology Printed in Great Britain
DOI: 10.1677/joe.1.06058
Online version via http://www.endocrinology-journals.org
between IGF-I and oestradiol have been detected in the
nervous system as well. As an endocrine signal, IGF-I
represents a link between the growth and reproductive
axes and the interaction between IGF-I and oestradiol in
the brain may be of particular physiological relevance for
the regulation of growth, sexual maturation and adult
neuroendocrine function.
Analysis of the distribution of IGF-I receptor and of the
two known forms of oestrogen receptors ( and ) in the
rat brain reveals that many brain cells express both types of
receptor and that most neural cells expressing IGF-I
receptor also express oestrogen receptors (Cardona-Gomez
et al. 2000a, Garcia-Segura et al. 2000). This suggests that
oestrogen and IGF-I may interact in diﬀerent brain regions
to regulate neural function. Such interactions have been
reported in brain areas involved in neuroendocrine control
(Fig. 1). For instance, there is an interdependence of
oestrogen receptors and IGF-I receptor in the promotion
of the survival and diﬀerentiation of developing hypo-
thalamic neurons (Toran-Allerand et al. 1988, Dueñas
et al. 1996, Cambiasso et al. 2000, Carrer & Cambiasso
2002). Both factors interact as well in the control of
synaptic plasticity in the arcuate nucleus, a key centre for
neuroendocrine regulation of the growth and reproductive
axes. Oestradiol increases IGF-I accumulation in the
arcuate nucleus during the oestrous cycle (Garcia-Segura
et al. 1994) and both oestrogen receptors and IGF-I
receptor are involved in the induction of synaptic and glial
plastic modifications in this brain area (Fernandez-Galaz
et al. 1997, 1999, Cardona-Gomez et al. 2000b). Further-
more, oestradiol and IGF-I interact in the control of
luteinizing hormone secretion at the hypothalamic level
(Hiney et al. 2004), and blockade of IGF-I receptor during
oestrogen priming blocks oestrogen-induced luteinizing
hormone release and partially inhibits hormone-dependent
reproductive behaviour (Quesada & Etgen 2002, Etgen
2003, Etgen & Acosta-Martinez 2003).
Another functional outcome of the interaction of IGF-I
with oestrogen in the brain is the regulation of adult
neurogenesis. Neural precursors located in the subgranular
zone of the dentate gyrus of the hippocampus proliferate in
adult rodents. The newly generated neurons are func-
tional, integrate in hippocampal circuits and may be
involved in certain forms of hippocampal-dependent
learning. IGF-I and oestradiol are among the molecules
that have been identified as modulators of adult neuro-
genesis (Tanapat et al. 1999, Trejo et al. 2001). The
intracerebroventricular administration of the oestrogen
receptor antagonist ICI 182 780 blocks IGF-I-induced
neurogenesis in adult ovariectomized rats (Perez-Martin
et al. 2003), suggesting that oestrogen receptors are in-
volved in the action of IGF-I on adult hippocampal
neurogenesis. This interaction of IGF-I with oestrogen
receptors may directly occur in the proliferating cells, since
they express receptors for both IGF-I and oestrogen
(Perez-Martin et al. 2003).
Interaction of oestradiol and IGF-I on
neuroprotection
IGF-I and oestradiol have neuroprotective properties and
prevent neuronal cell death in diﬀerent experimental
models of neurodegenerative diseases (Garcia-Segura
et al. 2001, Carro et al. 2003). The interaction of IGF-I
and oestradiol in neuroprotection has been assessed in
ovariectomized rats, using systemic administration of
kainic acid to induce degeneration of hippocampal hilar
neurons (Azcoitia et al. 1999), an experimental model
of excitotoxic cell death. Both the systemic administration
of oestradiol and the intracerebroventricular infusion of
IGF-I prevent hilar neuronal loss induced by kainic acid.
The neuroprotective eﬀect of oestradiol is blocked by the
intracerebroventricular infusion of the IGF-I receptor
antagonist JB-1, while the neuroprotective eﬀect of IGF-I
is blocked by the intracerebroventricular infusion of the
oestrogen receptor antagonist ICI 182 780 (Azcoitia et al.
1999). Similar results have been obtained after the uni-
lateral infusion of 6-hydroxydopamine into the medial
forebrain bundle to lesion the nigrostriatal dopaminergic
pathway, a model of Parkinson’s disease. Pretreatment
with oestrogen or IGF-I significantly prevents the loss of
Figure 1 Neural events where interactions between oestradiol (E) and IGF-I, or between oestrogen
receptors (ER) and IGF-I receptors (IGF-IR), have been documented.
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substantia nigra compacta neurons and the related motor
disturbances. Blockage of IGF-I receptors by intra-
cerebroventricular JB-1 attenuates the neuroprotective
eﬀects of both oestrogen and IGF-I (Quesada & Micevych
2004). These findings suggest that the neuroprotective
actions of oestradiol and IGF-I after brain injury depend on
the coactivation of both oestrogen receptors and IGF-I
receptor.
It should be noted that the studies which up to now
have assessed the interactions of oestrogen receptors and
IGF-I receptors in the brain in vivo have been conducted
on ovariectomized females. We may assume that similar
interactions will occur in the brains of intact females and in
the brains of males. However, the outcome of these
interactions may be diﬀerent in males than in females.
Although it is known that oestrogen and IGF-I may exert
neuroprotective actions in male rodents (Carro et al. 2003,
Garcia-Segura et al. 2001, 2003), there are several reports
of sex diﬀerences in the response to brain injury and in the
neuroprotective actions of oestradiol (Roof & Hall 2000,
Garcia-Segura et al. 2001, Galanopoulou et al. 2003,
Hilton et al. 2003). Furthermore, the potential eﬀects of
androgens on the interaction of oestrogen receptors and
IGF-I receptors in the brain have not been explored.
Mechanisms of crosstalk between oestradiol and
IGF-I in the brain
The abundant coexpression of oestrogen receptors with
IGF-I receptor in neurons and glia in the brain (Cardona-
Gomez et al. 2000a, Garcia-Segura et al. 2000) indicates
that interactions of the intracellular signalling pathways of
IGF-I receptor and oestrogen receptors are possible in
many brain cells. In diﬀerent cell lines, including neuro-
blastoma cells (Ma et al. 1994), IGF-I may activate
oestrogen receptors in the absence of oestradiol. Whether
or not this is also valid for the brain in vivo is unknown.
However, both in vitro and in vivo studies have shown that
oestradiol regulates the expression of IGF-I receptors in
neural tissue (Cardona-Gomez et al. 2001, El-Bakri et al.
2004) and activates the two main signal transduc-
tion cascades coupled to the IGF-I receptor: the
mitogen-activated protein kinase (MAPK) and the
phosphoinositide 3-kinase (PI3K) signalling pathways.
Estradiol induces a rapid activation of extracellular-
signal-regulated kinase (ERK) in primary cultures of
astroglia (Ivanova et al. 2001) and in explants of cerebral
cortex (Toran-Allerand et al. 1999, Singh et al. 2000,
Setalo et al. 2002). In addition, the oestradiol-induced
activation of ERK may be detected in vivo after systemic
administration of the hormone (Cardona-Gomez et al.
2003). ERK activation may be involved in the induction
of neurite arborization of cholinergic neurons by oestradiol
(Dominguez et al. 2004) and in the neuroprotective eﬀects
of the hormone (Singer et al. 1999, Garcia-Segura et al.
2000, Kuroki et al. 2001). Oestradiol also induces the
phosphorylation of protein kinase B, also known as the
kinase Akt, in primary neuronal cultures, in cerebral
cortical explants and in the adult rat brain in vivo (Singh
2001, Cardona-Gomez et al. 2002, Ivanova et al. 2002,
Wilson et al. 2002, Znamensky et al. 2003). Furthermore,
IGF-I and estradiol act synergistically to increase Akt
activity, but not ERK, in the rat brain (Cardona-Gomez
et al. 2002). Activation of Akt may regulate oestradiol-
induced synaptic plasticity (Znamensky et al. 2003) and
may also be involved in the neuroprotective eﬀects of
oestradiol (Garcia-Segura et al. 2000, Honda et al. 2000,
Zhang et al. 2001, Yu et al. 2004).
Glycogen synthase kinase 3 (GSK3), downstream of
Akt, may also be a point of interaction of oestrogen and
IGF-I signalling. Physiological phosphorylation of
microtubule-associated proteins by GSK3 may be in-
volved in the regulation of microtubule dynamics, neuritic
growth, synaptogenesis and synaptic plasticity (Hall et al.
2000). However, under pathological conditions, GSK3
may be responsible for the hyperphosphorylation of Tau in
Alzheimer’s disease (Lovestone et al. 1994) and its inhibi-
tion is associated with the activation of survival pathways
in neurons (Cross et al. 1995). Interestingly, oestradiol
regulates the activity of GSK3 and decreases the phos-
phorylation of Tau in the rat hippocampus in vivo
(Cardona-Gomez et al. 2004). Furthermore, oestradiol
increases the association of Tau with phosphorylated
GSK3, with the p85 subunit of the PI3K and with
-catenin, another substrate of GSK3 (Cardona-Gomez
et al. 2004). These observations are coherent with results
showing that systemic administration of oestradiol to adult
ovariectomized rats results in a transient increase in tyro-
sine phosphorylation of the IGF-I receptor, in a transient
interaction of the IGF-I receptor with the oestrogen
receptor , but not , and in an enhanced interaction of
oestrogen receptor  with the p85 subunit of the PI3K in
the brain (Mendez et al. 2003). All these findings suggest
that oestrogen receptor  may aﬀect IGF-I actions in the
brain by an interaction with some of the components of
IGF-I signalling, such as the IGF-I receptor, PI3K and
GSK3. A hypothetical model for these interactions is
presented in Figure 2.
The interaction of oestrogen receptor  with the sig-
nalling pathways of IGF-I receptor in the brain may
explain the interdependence of oestradiol and IGF-I in the
regulation of diﬀerent neural events. ERK and Akt may be
involved in the interaction of IGF-I and oestradiol in the
regulation of neuronal diﬀerentiation, synaptic function,
synaptic remodelling, neuroprotection and sexual behav-
iour. The synergistic interaction of IGF-I and oestradiol in
the phosphorylation of Akt may be critical for neuro-
protective actions. Akt regulates several transcription
factors that may be involved in the control of neuronal
survival, such as cAMP-response-element-binding
protein (CREB; Pugazhenthi et al. 2000), nuclear factor 
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(NF-B; Kane et al. 1999) and several members of the
Forkhead family (Brunet et al. 1999, Kops et al. 1999,
Tang et al. 1999). In addition, activation of Akt results in
the phosphorylation of the Bcl-2 family member Bad and
this may suppress Bad-induced cell death (Datta et al.
1997, del Peso et al. 1997). Furthermore, Akt activation
enhances Bcl-2 promoter activity (Pugazhenthi et al. 2000)
and both IGF-I and oestrogen induce Bcl-2 expression
in neurons. Interestingly, IGF-I receptor activation is
necessary for the induction of Bcl-2 by estradiol in the
adult brain (Cardona-Gomez et al. 2003). Also down-
stream of Akt, IGF-I and oestradiol may interact on the
regulation of microtubule dynamics, neuritic growth,
synaptogenesis, synaptic plasticity and neuronal survival,
acting on GSK3 and on its substrates, -catenin and Tau
(Cardona-Gomez et al. 2004).
Conclusions
The studies reviewed in this paper indicate that the
mechanisms of intracellular signalling of IGF-I and
oestradiol are intimately associated in the nervous system.
Oestrogen receptor  appears to be part of the signalling
Figure 2 Proposed model for the interaction of oestradiol and IGF-I in the brain. Oestradiol interacts with IGF-I at different levels,
regulating the activity and association of different proteins involved in the cellular response to IGF-I. (1) Oestradiol induces the
association of oestrogen receptor  (ER) with IGF-I receptor (IGF-IR), probably through an adapter protein. (2) Oestradiol increases
IGF-I receptor phosphorylation.(3) Oestradiol treatment modulates the interaction between oestrogen receptor  and p85. (4) Oestradiol
regulates the activity of protein kinases, increasing Akt phosphorylation. (5) Oestrogen receptor  interacts with GSK3 and -catenin,
and oestradiol decreases GSK3 activity, which in turn (6) decreases Tau phosphorylation. (7, 8) The associations of p85 and -catenin
with Tau are also increased upon oestradiol treatment in the brain. Some potential functional outcomes of these interactions are
indicated in the figure. IRS-1: insulin receptor substrate-1.
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mechanism of IGF-I in the brain. In turn, oestradiol
activates IGF-I receptor signalling in neurons and glia.
This interaction between IGF-I and oestradiol appears to
be relevant for the neuroprotective eﬀects of both factors.
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